OCI NV (OCI.AS) Stock Fundamental Analysis
AMS:OCI - NL0010558797 - Common Stock
4.774 EUR
+0.02 (+0.34%)
Overall OCI gets a fundamental rating of 3 out of 10. We evaluated OCI against 65 industry peers in the Chemicals industry. Both the profitability and financial health of OCI have multiple concerns. OCI has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
OCI had negative earnings in the past year.
In the past year OCI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: OCI reported negative net income in multiple years.
OCI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
OCI has a Return On Assets of -5.28%. This is in the lower half of the industry: OCI underperforms 72.31% of its industry peers.
With a Return On Equity value of -51.53%, OCI is not doing good in the industry: 87.69% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.28% | ||
| ROE | -51.53% | ||
| ROIC | N/A |
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OCI's Profit Margin has improved in the last couple of years.
OCI has a worse Gross Margin (2.23%) than 86.15% of its industry peers.
OCI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OCI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
2. Health
2.1 Basic Checks
OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OCI has about the same amount of shares outstanding.
OCI has more shares outstanding than it did 5 years ago.
OCI has a better debt/assets ratio than last year.
2.2 Solvency
OCI has an Altman-Z score of 0.15. This is a bad value and indicates that OCI is not financially healthy and even has some risk of bankruptcy.
OCI has a Altman-Z score of 0.15. This is amonst the worse of the industry: OCI underperforms 83.08% of its industry peers.
The Debt to FCF ratio of OCI is 44.52, which is on the high side as it means it would take OCI, 44.52 years of fcf income to pay off all of its debts.
OCI has a Debt to FCF ratio of 44.52. This is comparable to the rest of the industry: OCI outperforms 49.23% of its industry peers.
OCI has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.
OCI's Debt to Equity ratio of 2.03 is on the low side compared to the rest of the industry. OCI is outperformed by 90.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | 44.53 | ||
| Altman-Z | 0.15 |
ROIC/WACCN/A
WACC5.8%
2.3 Liquidity
A Current Ratio of 1.39 indicates that OCI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.39, OCI is not doing good in the industry: 67.69% of the companies in the same industry are doing better.
A Quick Ratio of 1.37 indicates that OCI should not have too much problems paying its short term obligations.
OCI has a Quick ratio of 1.37. This is in the better half of the industry: OCI outperforms 67.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
OCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -123.19%.
The Earnings Per Share has been growing by 105.88% on average over the past years. This is a very strong growth
Looking at the last year, OCI shows a very negative growth in Revenue. The Revenue has decreased by -58.51% in the last year.
The Revenue for OCI have been decreasing by -20.30% on average. This is quite bad
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
3.2 Future
Based on estimates for the next years, OCI will show a very strong growth in Earnings Per Share. The EPS will grow by 60.21% on average per year.
The Revenue is expected to decrease by -14.70% on average over the next years. This is quite bad
EPS Next Y607.7%
EPS Next 2Y198.9%
EPS Next 3Y46.17%
EPS Next 5Y60.21%
Revenue Next Year-30.61%
Revenue Next 2Y-14.94%
Revenue Next 3Y-25.58%
Revenue Next 5Y-14.7%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
OCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 16.63, OCI is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OCI indicates a somewhat cheap valuation: OCI is cheaper than 64.62% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, OCI is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 16.63 |
4.2 Price Multiples
OCI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. OCI is cheaper than 72.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.9 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
OCI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OCI's earnings are expected to grow with 46.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y198.9%
EPS Next 3Y46.17%
5. Dividend
5.1 Amount
No dividends for OCI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:OCI (9/8/2025, 1:46:09 PM)
4.774
+0.02 (+0.34%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners32.13%
Inst Owner ChangeN/A
Ins Owners8.71%
Ins Owner ChangeN/A
Market Cap1.01B
Analysts71.67
Price Target8.19 (71.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend13.03
Dividend Growth(5Y)N/A
DP-36.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)486.8%
Min EPS beat(2)232.01%
Max EPS beat(2)741.58%
EPS beat(4)2
Avg EPS beat(4)85.49%
Min EPS beat(4)-492.57%
Max EPS beat(4)741.58%
EPS beat(8)3
Avg EPS beat(8)31.49%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)37.56%
Min Revenue beat(2)20.15%
Max Revenue beat(2)54.98%
Revenue beat(4)2
Avg Revenue beat(4)8.41%
Min Revenue beat(4)-23.05%
Max Revenue beat(4)54.98%
Revenue beat(8)5
Avg Revenue beat(8)21.58%
Revenue beat(12)9
Avg Revenue beat(12)32.19%
Revenue beat(16)12
Avg Revenue beat(16)36.43%
PT rev (1m)-27.63%
PT rev (3m)-31.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-24.33%
EPS NY rev (3m)-24.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)4.64%
Revenue NY rev (3m)-3.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 16.63 | ||
| P/S | 0.26 | ||
| P/FCF | 21.9 | ||
| P/OCF | 2.13 | ||
| P/B | 1.28 | ||
| P/tB | 1.36 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.41
EYN/A
EPS(NY)0.29
Fwd EY6.01%
FCF(TTM)0.22
FCFY4.57%
OCF(TTM)2.24
OCFY46.85%
SpS18.41
BVpS3.72
TBVpS3.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.28% | ||
| ROE | -51.53% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.23% | ||
| FCFM | 1.18% |
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score3
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | 44.53 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | -4159.17% | ||
| Cap/Sales | 10.96% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 0.15 |
F-Score3
WACC5.8%
ROIC/WACCN/A
Cap/Depr(3y)137.7%
Cap/Depr(5y)97.09%
Cap/Sales(3y)24.99%
Cap/Sales(5y)17.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
EPS Next Y607.7%
EPS Next 2Y198.9%
EPS Next 3Y46.17%
EPS Next 5Y60.21%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
Revenue Next Year-30.61%
Revenue Next 2Y-14.94%
Revenue Next 3Y-25.58%
Revenue Next 5Y-14.7%
EBIT growth 1Y-118.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year309.47%
EBIT Next 3Y-17.67%
EBIT Next 5Y-4.61%
FCF growth 1Y-95.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.4%
OCF growth 3Y-68.9%
OCF growth 5Y-27.39%